PTEN and invasive carcinoma: Immunohistochemistry (IHC) showed low ETS-related gene (ERG) positivity prevalence (1/15), with partial or complete loss of PTEN in roughly half the cases (7/15), and 56% of discordance for the nine cases with sufficient tissue to evaluate adjacent invasive carcinoma.